Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway
Frontiers in Oncology · 01.04.2026 · 16
DOI: 10.3389/fonc.2026.1744705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 01.04.2026. Verfasst von Wei Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Glioma, the most common primary intracranial tumor, exhibits high recurrence and mortality rates. Ginsenoside-Rh2 (GS-Rh2), an active compound from Panax ginseng , has shown anti-tumor potential. Gab2, a tyrosine kinase substrate, is implicated in glioma pathogenesis; however, the mechanism by which GS-Rh2 might inhibit glioma cell migration and invasion via the Gab2/Akt2 pathway remains unexplored.
Objective
To investigate the effects and mechanisms of GS-Rh2 on glioma cell migration and invasion through the Gab2/Akt2 signaling pathway.
Methods
U251 glioma cells were treated with GS-Rh2 in vitro . Cell viability was assessed by MTT assay. Western blot was used to detect Gab2 and p-Akt2 expression. In vivo , GS-Rh2 was administered to nude mice bearing U251 or siGab2/U251 intracranial xenografts. HE staining assessed brain invasion, and western blot detected Gab2 and Akt2 expression in tumor tissues.
Results
GS-Rh2 significantly inhibited U251 cell proliferation, migration, and invasion both in vitro and in vivo ( P < 0.05), while no significant effects were observed in siGab2/U251 cells. At the molecular level, GS-Rh2 significantly reduced Gab2 expression and Akt2 phosphorylation in U251 cells and brain tumor tissues ( P < 0.05).
Conclusions
GS-Rh2 inhibits migration and invasion of U251 glioma cells by decreasing Gab2 expression and Akt2 phosphorylation, suggesting that GS-Rh2 targets the Gab2/Akt2 signaling axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Department of Pathogenic Biology, Shandong Second Medical University, Weifang, China.
- Department of Rehabilitation, Weifang Hospital of Traditional Chinese Medicine, Weifang, China.
- Hemodialysis Room, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Qingdao Medical College, Qingdao University, Qingdao, China.
Zitieren
APA
Sun, W., Li, R., Wang, L., Han, W., Li, J., Xu, S., & Sun, X. (2026). Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1744705
Vancouver
Sun W, Li R, Wang L, Han W, Li J, Xu S, et al. Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1744705
BibTeX
@article{Sun2026,
author = {Sun, Wei and Li, Ruifang and Wang, Linjuan and Han, Wenjie and Li, Jiake and Xu, Shuangli and Sun, Xiuning},
title = {Ginsenoside-Rh2 inhibits U251 glioma cell migration and invasion via the Gab2/Akt2 pathway},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1744705}
}
EUVIMED